Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

The Indian Army is a prestigious institution that plays a vital role in keeping the country safe And that is exactly why the ...